Patent Assignment
Reel/Frame 050399/0679
Release of Security Interest
Recorded: 2019-09-17
Pages: 10
Assignor
10X FUND L.P.
Executed: 2019-07-29
Assignee
GALECTIN THERAPEUTICS, INC.
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GEORGIA, 30071
Covered Properties
(15)
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Patent:
6,645,946 →
Application:
09/818,596 →
Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments
Modified polysaccharides for treatment of cancer
Application:
10/041,350 →
Publication:
US 2002/0107222
Co-Administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer
Methods and compositions for reducing side effects in chemotherapeutic treatments
Application:
10/354,750 →
Publication:
US 2003/0229028
Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
Application:
10/557,120 →
Publication:
US 2007/0258969
Compositions and methods used to treat acne and candida
Application:
10/597,930 →
Publication:
US 2007/0078109
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
Application:
10/657,508 →
Publication:
US 2005/0053664
Compositions and methods for hydrophobic drug delivery
Application:
10/889,555 →
Publication:
US 2005/0043272
Compositions and methods to inhibit restenosis
Application:
11/103,310 →
Publication:
US 2005/0239743
Modified polysaccharides in combination with anti-cancer drugs for enhanced treatment of cancer
Application:
11/182,096 →
Publication:
US 2005/0282773
Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins
Application:
11/659,170 →
Publication:
US 2008/0286251
Galactose-Pronged Polysaccharides in a Formulation for Antifibrotic Therapies
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 31, 2001
From: KLYOSOV, ANATOLE; PLATT, DAVID
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 012420/0451 →
Assignment of Assignor's Interest
Jun 30, 2003
From: KLYOSOV, ANATOLE; PLATT, DAVID
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 014226/0037 →
Assignment of Assignor's Interest
Jan 30, 2004
From: ZOMER, ELI; PLATT, DAVID
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 014947/0718 →
Assignment of Assignor's Interest
Nov 12, 2004
From: PLATT, DAVID; ZOMER, ELIEZER; KLYOSOV, ANATOLE
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 015977/0846 →
Assignment of Assignor's Interest
Jul 7, 2005
From: ZOMER, ELIEZER; PLATT, DAVID; KLYOSOV, ANATOLE
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 016752/0836 →
Assignment of Assignor's Interest
Jul 15, 2005
From: PLATT, DAVID
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 016788/0474 →
Assignment of Assignor's Interest
Sep 16, 2005
From: KLYOSOV, ANATOLE
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 016811/0436 →
Assignment of Assignor's Interest
Oct 30, 2006
From: PLATT, DAVID, DR.; ZOMER, ELIEZER, DR.; KLYOSOV, ANATOLE, DR.
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 018455/0128 →
Assignment of Assignor's Interest
Dec 4, 2006
From: PLATT, DAVID, DR.; ZOMER, ELIEZER, DR.
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 018580/0338 →
Assignment of Assignor's Interest
Mar 1, 2007
From: KLYOSOV, ANATOLE, DR.; PLATT, DAVID, DR.
To: PRO-PHARMACEUTICALS, INC
Reel/Frame 018942/0817 →
Assignment of Assignor's Interest
Mar 1, 2007
From: KLYOSOV, ANATOLE, DR.; PLATT, DAVID, DR.
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 018942/0833 →
Change of Name
Jun 4, 2007
From: SAFESCIENCE, INC.
To: GLYCOGENESYS, INC.
Reel/Frame 019365/0596 →
Court Appointment of Trustee
Jun 4, 2007
From: GLYCOGENESYS, INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
Reel/Frame 019365/0501 →
Assignment of Claims
Jun 4, 2007
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 019365/0510 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019365/0568 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: GLYCOGENESYS, INC.
Reel/Frame 019365/0599 →
Change of Name
Jun 4, 2007
From: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
To: PROSPECT PHARMACEUTICALS, INC.
Reel/Frame 019365/0633 →
Change of Name
Jun 4, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 019365/0638 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: GLYCOGENESYS, INC.
Reel/Frame 019375/0467 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: GLYCOGENESYS, INC.
Reel/Frame 019375/0493 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019390/0900 →
Assignment of Assignor's Interest
Dec 22, 2008
From: PLATT, DAVID; ZOMER, ELIEZER
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 022013/0673 →
Assignment of Assignor's Interest
Dec 22, 2008
From: PLATT, DAVID; ZOMER, ELIEZER; KLYOSOV, ANATOLE
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 022013/0445 →
Security Agreement
Aug 26, 2009
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023134/0968 →
Assignment of Assignor's Interest
Sep 4, 2009
From: PLATT, DAVID, DR.; ZOMER, ELIEZER, DR.; KLYOSOV, ANATOLE, DR.
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 023195/0598 →